Vivos Therapeutics Inc (VVOS)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
2,830,600
EV to revenue ratio (TTM)
0.708
EV to ebitda
-0.213
Financial Performance
Revenue (TTM)
20,902,000
Gross profit (TTM)
12,938,000
EBITDA
-20,763,000
Profitability
Operating margin (TTM)
-93.60%
Profit margin
-121.80%
Return on assets (TTM)
-56.20%
Return on equity (TTM)
-8,585.00%
Per Share Metrics
Revenue per share (TTM)
1.5
EPS
-1.88
Diluted EPS (TTM)
-1.88
Book value
-0.34
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
0.135
Price to book ratio (TTM)
6.86
Growth
Quarterly earnings growth (YoY)
34.90%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
0
Buy
2
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
6